Company Analysis
Sign in

Replimune Group, Inc. (REPL)

Nasdaq: REPL · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2018
Full chart Alerts Compare
Grade5.0
◀ Past 5.6● Present 4.3▶ Future 5.3
7 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Who owns Replimune Group, Inc.

As filed with the SEC
Holders of 5% or more
5
Baker Bros. Advisors LP holds 11.8% of Common Stock, $0.001 par value per share, as its SCHEDULE 13D/A filed Aug 11, 2026 says.
Directors and officers
n/a
The record holds no Form 3, 4 or 5 for this company yet.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Baker Bros. Advisors LP
SCHEDULE 13D/A · filed Aug 11, 2026 · Common Stock, $0.001 par value per share · 14.3% in Mar 7, 2025
11.8%
RTW Investments, LP
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.001 par value · 8.2% in Nov 14, 2025
8.9%
Montanova Capital, LLC
SCHEDULE 13G/A · filed Aug 6, 2026 · Common Stock, par value $0.001 per share · 5.1% in May 12, 2026
7.9%
Goldman Sachs Group Inc.
SCHEDULE 13G · filed Aug 10, 2026 · Common Stock, par value $0.001 per share
5.3%
State Street Corporation
SCHEDULE 13G · filed Aug 7, 2026 · COMMON STOCK
5.3%
Ridgeback Capital Investments L.P.
SCHEDULE 13G/A · filed Aug 14, 2026 · Common stock, par value $0.001 per share · reported falling below 5%, from 7.6% in May 21, 2026
under 5%
The Vanguard Group
SCHEDULE 13G/A · filed Jan 31, 2025 · Common Stock · reported falling below 5%
under 5%
Point72 Asset Management, L.P.
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%, from 5.7% in Jul 31, 2025
under 5%
Forbion Capital Fund III Cooperatief U.A.
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 6.1% in Feb 14, 2025
under 5%
Redmile Group, LLC
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%, from 6.4% in May 15, 2025
under 5%
T. Rowe Price Associates, Inc.
SCHEDULE 13G/A · filed May 7, 2026 · COMMON STOCK · reported falling below 5%, from 10.6% in Nov 14, 2025
under 5%
What REPL reports owning in othersstakes of 5% or more, and other ties

4 subsidiaries in 3 countries, from the list filed with the 10-K filed Jun 29, 2026.

Insider tradesForm 4
The record holds no insider filings for this company yet.
SI Assistanton REPL · research, not advice